Pharmaceutical

Moderna pauses plans to build mRNA facility in Kenya

Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.

Apr 13, 2024 - 00:00
Moderna pauses plans to build mRNA facility in Kenya
Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.
Read the original article

Tags:

Previous Article

Century secures $60m in stock sale and buys preclinical cell therapy biotech

Next Article

Fujifilm invests $1.2bn ramping up North Carolina facility

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Masimo’s CEO on battling Apple for the health wearable market

STAT+: Masimo’s CEO on battling Apple for the health we...

May 15, 2023

Opinion: How journalists can cover RFK Jr.’s antivax presidential run responsibly

Opinion: How journalists can cover RFK Jr.’s antivax pr...

Apr 25, 2023

EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia

EC marketing authorisation granted to Pfizer’s HYMPAVZI...

Nov 21, 2024